Mitotane
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C14H10Cl4 320.04
Benzene, 1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]-, (RS)-; (±)-1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane CAS RN: 53-19-0; UNII: 78E4J5IB5J.
1 DEFINITION
Mitotane contains NLT 97.0% and NMT 103.0% of mitotane (CHCI), calculated on the anhydrous basis.
[CAUTION-Handle Mitotane with exceptional care, because it is a highly potent agent.]
2 IDENTIFICATION
Change to read:
A. SPECTROSCOPIC IDENTIFICATION TESTS (197), Infrared Spectroscopy: 197M or 197A (RB 1-Aug-2023)
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
Change to read:
PROCEDURE
Buffer: 1.38 g/L of monobasic potassium phosphate in water. Adjust with phosphoric acid to a pH of 2.5.
Mobile phase: Acetonitrile and Buffer (75:25)
System suitability solution: 0.2 mg/ml. of USP Mitotane RS and 0.2 mg/mL of USP Mitotane Related Compound A RS in Mobile phase (RB 1-Aug-2023)
Standard solution: 0.2 mg/mL of USP Mitotane RS in Mobile phase
Sample solution: 0.2 mg/mL of Mitotane in Mobile phase. [NOTE-Inject within 48 h of preparation.]
Chromatographic system
(See Chromatography (621) System Suitability.)
Mode: LC
Detector: UV 230 nm
Column: 4.6-mm x 25-cm; 5-µm packing L1
Flow rate: 1 mL/min
Injection volume: 10 µL
System suitability
Samples: System suitability solution and Standard solution
[NOTE-The relative retention times for mitotane related compound A (RB 1-Aug-2023) and mitotane are about 0.92 and 1.0, respectively.]
Suitability requirements
Resolution: NLT 1.5 between mitotane related compound A (RB 1-Aug-2023) and mitotane, System suitability solution
Tailing factor: NMT 1.5, Standard solution
Relative standard deviation: NMT 1.0%, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of mitotane (C14H10Cl4) in the portion of Mitotane taken:
Result = (ru /rs ) × (Cs /Cu ) × 100
ru = peak response of mitotane from the Sample solution
rs = peak response of mitotane from the Standard solution
Cs = concentration of USP Mitotane RS in the Standard solution (mg/mL)
Cu = concentration of Mitotane in the Sample solution (mg/mL)
Acceptance criteria: 97.0%–103.0% on the anhydrous basis
4 IMPURITIES
RESIDUE ON IGNITION (281): NMT 0.5%
Delete the following:
ORGANIC IMPURITIES (RB 1-Aug-2023)
5 SPECIFIC TESTS
WATER DETERMINATION (921), Method / Method la: NMT 0.5%
6 ADDITIONAL REQUIREMENTS
Change to read:
PACKAGING AND STORAGE: Preserve in tight, light-resistant containers. Store at room temperature (RB 1-Aug-2023)
Change to read:
USP REFERENCE STANDARDS (11)
USP Mitotane RS
USP Mitotane Related Compound A RS
2,2-Bis(4-Chlorophenyl)-1,1-dichloroethane.
C14H10Cl4 320.04 (RB 1-Aug-2023)

